Book a demo
Research & KnowledgeEvent: September 7, 2026

Johnson & Johnson | Vision published a study on the DoGE effect

Published

Signal category

Research & Knowledge

Quote

DoGE effect

Gopinath Mavankal|Johnson & Johnson | Vision team

Company

Johnson & Johnson | Vision

As J&J MedTech, a leader in eye health, we are paving the way for a new future of vision care at every stage of life.

Industry
Medical Equipment Manufacturing
Location
Jacksonville, US
Company size
5,451 employees

As a leader in eye health and part of Johnson & Johnson MedTech, we are driven by a bold ambition: Vision Made Possible™— paving the way for a new future of eye health to support the full spectrum of pediatric, adult and aging eyes. Our priority is to deliver on the eye health needs of more than 44 million patients around the world every year. Poor eye health has reached epidemic proportions and access to care around the world remains inequitable and disconnected – and we believe that we have the opportunity—and responsibility—to do more. Sight is a key component in the way many of us experience the world, learn and remember, and what many fear losing the most. We are driven to reimagine and deliver the most all-encompassing eyecare to meet the unique needs of every patient. Understanding that eye health needs change over a lifetime—from contacts to cataracts, we have built a unified, global organization that collaborates, innovates, and works seamlessly together to care for patients at every stage in their eye health journey. Through cutting-edge innovation, scientific expertise, and advanced technologies, we stand as a trusted partner, making dependable outcomes possible for our customers and patients.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.